摘要
目的 探讨盐酸替罗非班治疗冠脉介入治疗过程中出现的无复流的疗效.方法 选择2012年3月～2013年2月华西医院收治的急性心肌梗死患者在急诊冠脉介入治疗中出现的56例无复流的患者作为临床观察对象,使用盐酸替罗非班注入IRA治疗.结果 在使用盐酸替罗非班（欣维宁）之后,经皮冠状动脉介入（PCI）成功率均达100%,TIMI 3级血流发生率100%.结论 冠脉介入治疗中出现的无复流患者应用盐酸替罗非班安全、有效,能改善冠脉微循环及心肌灌注.
Objective To study the efficacy of Tirofiban in treating no-reflow in the course of coronary interventional. Methods From 2012 March to 2013 February in West China Hospital, 56 myocardial infarction patients with no-reflow as clinical observation object, used tirofiban injection treating IRA. Results Percutaneous coronary intervention （ PCI ） success rate reached 100%, TIMI 3 flow rate 100%. Conclusion Tirofiban might safe and effective in treating no-fellow in the course of cor- onary interventional, it could improve the microcirculation of coronary artery and myocardial perfusion.
出处
《四川医学》
CAS
2013年第9期1346-1348,共3页
Sichuan Medical Journal
关键词
急性心肌梗死
经皮冠状动脉介入治疗
盐酸替罗非班
无复流现象
acute myocardial infarction
percutaneous coronary intervention
whether tirofiban
no-reflow phenomenon
